Trade Ideas

Actionable trade ideas with defined risk and time horizons.

Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.

Articles

10,935 total articles

Doubling Down on Uber After the Pullback: A Measured, Risk-Weighted Play

Doubling Down on Uber After the Pullback: A Measured, Risk-Weighted Play

Uber fell into a deep pullback recently; at current levels the company trades at mid-teens earnings multiple with $9.1B in free cash flow and a $144B market cap. I’m adding to my position with a position-sized buy, a tight stop below the recent low, and a target that prices in recovery in mobility and delivery margins. This is a trade for investors…

argenx Upgrade: Vyvgart's Commercial Runway Still Has Room to Run

argenx Upgrade: Vyvgart's Commercial Runway Still Has Room to Run

argenx's VYVGART franchise is entering a new phase after broad FDA label expansion and encouraging CIDP data. With a $56.9B market cap, a clear path to multi-billion dollar sales, and improving trial dynamics across neuromuscular indications, the risk/reward favors buying weakness. This trade idea lays out an entry, stop, and target for a long-term…

Telkom Indonesia - Upgrade to Bullish After Clear Execution Signals

Telkom Indonesia - Upgrade to Bullish After Clear Execution Signals

Telkom Indonesia (TLKM) looks poised to re-rate after a string of positive operational updates: steady broadband subscriber growth, faster-than-expected migration to fixed broadband and 5G-capable customers, and clearer capital allocation priorities from management. We move to a bullish stance and recommend a tactical long with defined entry, stop,…

Lyft: The Rebound Worked, but a Full Re-Rating Still Needs Proof

Lyft: The Rebound Worked, but a Full Re-Rating Still Needs Proof

Lyft's operational rebound and stronger free cash flow have already driven a meaningful bounce in the stock. The business is cheaper than most expect on trailing metrics, but the market wants evidence that profitability and durable unit economics will scale before multiples expand. This idea lays out a defined long trade with entry, stop, target, a…

Intel as an AI Inference Play: Buy the Reset, Back the Execution

Intel as an AI Inference Play: Buy the Reset, Back the Execution

Intel is re-emerging as a credible AI-inference supplier and foundry player. Recent results show accelerating revenue (Q2 sales up 25% YoY to $16.1B) and improving margins, but the stock has pulled back enough to offer a risk/reward favorable to buyers. This trade targets recovery of multiple expansion and continued AI-driven revenue gains with cle…

Buy the Capex Dip in Alphabet: Cloud Profitability Is Already Landing

Buy the Capex Dip in Alphabet: Cloud Profitability Is Already Landing

Alphabet's stock pulled back as investors digested heavy AI infrastructure spending. Google Cloud's 82% year-over-year revenue growth to $24.8B and a tripling of operating income to $8.8B show the spending is starting to pay off. With a $4.06T market cap, sizable free cash flow ($53.27B) and a valuation that discounts durable multi-product monetiza…

RYAM Trade Setup: Buy the Gap to a Previously Rejected Cash Offer

RYAM Trade Setup: Buy the Gap to a Previously Rejected Cash Offer

Rayonier Advanced Materials (RYAM) trades at $8.65, well below levels where an earlier cash approach was reportedly rebuffed. The company's valuation and event set create an asymmetric long opportunity for disciplined traders who accept operational and leverage risk. Entry $8.60, target $11.00, stop $7.80; horizon: long term (180 trading days).

Nvidia: Time to Put a Big Stake in the AI Leader

Nvidia: Time to Put a Big Stake in the AI Leader

Nvidia remains the primary beneficiary of the AI build-out. Strong free cash flow, rock-solid returns on capital and expanding enterprise demand give shareholders asymmetric upside. This trade targets a large, conviction-weighted long over the next 180 trading days with clear entry, stop and target levels and a candid look at the biggest risks.

Wakix Profits Buy Optionality: A Tactical Long on Harmony Biosciences

Wakix Profits Buy Optionality: A Tactical Long on Harmony Biosciences

Harmony Biosciences is profitable, cash-flow positive and trading at a reasonable multiple with a ~$2.2B market cap. WAKIX cash generation gives management the flexibility to pursue label expansion, modest M&A or additional commercialization spend without equity dilution. This trade targets a re-rating and commercial upside over the next 45 trading…

Celestica: AI Capex + Strong Ops = A Material Mispricing

Celestica: AI Capex + Strong Ops = A Material Mispricing

Celestica reported blowout growth and raised full‑year guidance while the market sold off into that strength. With $19B revenue guidance, improving free cash flow, and direct exposure to hyperscaler AI server builds, the stock is materially underpricing growth. This trade idea lays out an entry at the current level, a protective stop and an upside …